Checkpoint Therapeutics
CKPT
CKPT was delisted on the 29th of May, 2025.
0 hedge funds and large institutions have $0 invested in Checkpoint Therapeutics in 2025 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 83 closing their positions.
41.04% less ownership
Funds ownership: 41.04% → 0% (-41%)
100% less funds holding
Funds holding: 84 → 0 (-84)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
100% less capital invested
Capital invested by funds: $138M → $0 (-$138M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 83
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Beryl Capital Management
Redondo Beach,
California
|
-$24.5M |
| 2 |
HCM
Highbridge Capital Management
New York
|
-$15.5M |
| 3 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$13.8M |
| 4 |
GCL
Glazer Capital LLC
New York
|
-$12.8M |
| 5 |
OBAM
ODDO BHF Asset Management
Paris,
France
|
-$8.79M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CI
76
Cordant Inc
Portland,
Oregon
| – | -$6.26K | -1,550 | Closed |
|
77
Jones Financial Companies
Des Peres,
Missouri
| – | -$5.38K | -1,332 | Closed |
|
78
Wells Fargo
San Francisco,
California
| – | -$4.04K | -1,000 | Closed |
|
|
TFGT
79
TS Financial Group (TSFG)
Lake Forest,
Illinois
| – | -$1K | -300 | Closed |
|
|
SS
80
SBI Securities
Tokyo,
Japan
| – | -$497 | -123 | Closed |
|
|
LFG
81
Larson Financial Group
St Louis,
Missouri
| – | -$404 | -100 | Closed |
|
82
BNP Paribas Financial Markets
Paris,
France
| – | -$396 | -98 | Closed |
|
83
JP Morgan Chase
New York
| – | -$4 | -1 | Closed |
|
CKPT Hedge Fund Activity: Q2 2025 in Review
0 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Checkpoint Therapeutics (CKPT) for Q2 2025, worth a combined $0 — down 100% from $138M a quarter earlier.
Sellers outnumbered buyers: 83 funds closed out of CKPT and 0 opened new positions — a net loss of 83 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Beryl Capital Management, exiting entirely with an estimated $24.5M sold.
- 0 institutional investors held Checkpoint Therapeutics (CKPT) as of Q2 2025, down from 84 in Q1 2025.
- Funds reported $0 of Checkpoint Therapeutics stock for Q2 2025, down 100% quarter-over-quarter.
- 0 funds opened new Checkpoint Therapeutics positions in Q2 2025 and 83 closed out, a net change of -83 holders.
- The largest Checkpoint Therapeutics seller in Q2 2025 was Beryl Capital Management, an estimated $24.5M sold.
Based on aggregated 13F filings for Q2 2025.